Clinical Trial Update: Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

View source ↗

Summary

This trial update reports results from Study P04083 evaluating high-dose interferon alfa-2b (Intron A) as adjuvant therapy for malignant melanoma; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Intron A (interferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Melanoma | Status: COMPLETED | Results posted: 2011-03-24